Tags |
|
|
Links |
|
|
Advice Pool - How to Write a Credit Policy for Your Business
The book, “Become the Squeaky Wheel,” by New Hampshire auth
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
or Michelle Dunn, says the different ways people use and ex
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
end credit makes or breaks your credit policy and bottom l
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ne, which could result in less or more sales and money for
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
our business.
“Business owners all have different types of
“Business owners all have different types of
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
businesses but can all extend credit,” explains Michelle Du
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
nn. “So it should only make sense that no two credit polic
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s can be the same.”
Dunn explains that one major differenc
Dunn explains that one major differenc
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
is if you have a service or retail business. Your credit
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
olicy should use multiple facets to cater to prospective cu
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
tomers but also protect the business owner.
“You are limit
“You are limit
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ed in what you can and can’t ask a prospective customer in
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
rder to extend them credit,” says Dunn. “Business owners n
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ed to be aware of what these questions are and what the law
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
are before they create their credit policy.” Your credit
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
olicy helps to filter customers so you don’t have to spend
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
your time chasing your money. Your best policy will be shor
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
, easy and to the point, it will avoid long-winded statemen
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
s and a lot of legal or big words. Always create your form
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
with the reader in mind, the easier and clearer the better
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/43366/advicepool-How-to-Write-a-Credit-Policy-for-Your-Business.html">How to Write a Credit Policy for Your Business</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/43366/advicepool-How-to-Write-a-Credit-Policy-for-Your-Business.html]How to Write a Credit Policy for Your Business[/url]
Related Articles:
Business Analysis: Giving Your Company the Edge
Bookmark it:
|